|
|
|
|
| |
| ImmunoCAP |
| [Description] |
| ImmunoCAP is a complete system of instrumentation, software and reagents to quantify the type and quantity of hundreds of allergen producing antibodies. The ImmuniCAP system is manufactured by Phadia, the world's leader in immuno-disgnostics. The ImmunoCAP system allows physicians to determine the exact cause or causes of the allergies and asthmas that affect a high percentage of the population. The ImmunoCAP uses a small blood sample to determine which allergen antibodies (IgE, IgG and IgA) are present, and to determine the quantity of each of these antibodies. |
| [Diagnosis] |
| The ImmunoCAP system is able to determine the level of hundreds of allergen antibodies originating from animals, dust mites, trees and other plants, insects and environmental sources. This allergy testing is key to determining the cause of the allergy, the likely route or progress of the developing allergy and thus the most effective allergy management strategy. In addition, the ImmunoCAP system can be used to diagnose and monitor treatment for auto?immune diseases such as rheumatoid arthritis. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
|
|
|
|
|
|
|
|
